New PBS listing brings immunotherapy option to Australians with rare head and neck cancer

Christine Cockburn, CEO of Rare Cancers Australia, welcomed the PBS decision as a long-awaited step forward. “For too long, patients with rare cancers have had limited treatment options and faced high costs to access the latest therapies." …